RAC1 and prostate cancer: In this study, after Arf6 was downregulated, both the cell proliferative capacity and Rac1 expression reduced, indicating that the molecular mechanism by which prostate cancer cell proliferation was suppressed by Arf6 downregulation may be the downregulation of Rac1 expression.